Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

Lancet Respiratory Medicine
Nov 2021 Volume 9 Number 11 p1203-1342, e104-e109
https://www.thelancet.com/journals/lanres/issue/current

 

Articles
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
David Hillus, et al.